Any feedback?
Please rate this page
(sequences.php)
(0/150)

BRENDA support

Sequence of CP21A_HUMAN

EC Number:1.14.14.16

EC Number
Recommended Name
Accession Code
Organism
No of amino acids
Molecular Weight [Da]
Source
steroid 21-monooxygenase
P08686
Homo sapiens
494
55887
Reaction
a C21 steroid + [reduced NADPH-hemoprotein reductase] + O2 = a 21-hydroxy-C21-steroid + [oxidized NADPH-hemoprotein reductase] + H2O
Other sequences found for EC No. 1.14.14.16

General information:

Sequence
show sequence in fasta format
  0 MLLLGLLLLP LLAGARLLWN WWKLRSLHLP PLAPGFLHLL QPDLPIYLLG LTQKFGPIYR
 60 LHLGLQDVVV LNSKRTIEEA MVKKWADFAG RPEPLTYKLV SKNYPDLSLG DYSLLWKAHK
120 KLTRSALLLG IRDSMEPVVE QLTQEFCERM RAQPGTPVAI EEEFSLLTCS IICYLTFGDK
180 IKDDNLMPAY YKCIQEVLKT WSHWSIQIVD VIPFLRFFPN PGLRRLKQAI EKRDHIVEMQ
240 LRQHKESLVA GQWRDMMDYM LQGVAQPSME EGSGQLLEGH VHMAAVDLLI GGTETTANTL
300 SWAVVFLLHH PEIQQRLQEE LDHELGPGAS SSRVPYKDRA RLPLLNATIA EVLRLRPVVP
360 LALPHRTTRP SSISGYDIPE GTVIIPNLQG AHLDETVWER PHEFWPDRFL EPGKNSRALA
420 FGCGARVCLG EPLARLELFV VLTRLLQAFT LLPSGDALPS LQPLPHCSVI LKMQPFQVRL
480 QPRGMGAHSP GQNQ
Download this sequence
in fasta format
Download all sequences for 1.14.14.16
in fasta format
in csv (Excel, OpenOffice) format
Sequence related references
Sequence Reference
Authors
Title
Journal
Volume
Pages
Year
PubMed ID
783929
Higashi Y.,Yoshioka H.,Yamane M.,Gotoh O.,Fujii-Kuriyama Y.
Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene.
Proc. Natl. Acad. Sci. U.S.A.
83
2841-2845
1986
783930
White P.C.,New M.I.,Dupont B.
Structure of human steroid 21-hydroxylase genes.
Proc. Natl. Acad. Sci. U.S.A.
83
5111-5115
1986
783931
Rodrigues N.R.,Dunham I.,Yu C.Y.,Carroll M.C.,Porter R.R.,Campbell R.D.
Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia.
EMBO J.
6
1653-1661
1987
783932
Globerman H.,Amor M.,Parker K.L.,New M.I.,White P.C.
Nonsense mutation causing steroid 21-hydroxylase deficiency.
J. Clin. Invest.
82
139-144
1988
783933
Helmberg A.,Tusie-Luna M.-T.,Tabarelli M.,Kofler R.,White P.C.
R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions.
Mol. Endocrinol.
6
1318-1322
1992
783934
Blasko B.,Banlaki Z.,Gyapay G.,Pozsonyi E.,Sasvari-Szekely M.,Rajczy K.,Fust G.,Szilagyi A.
Linkage analysis of the C4A/C4B copy number variation and polymorphisms of the adjacent steroid 21-hydroxylase gene in a healthy population.
Mol. Immunol.
46
2623-2629
2009
783935
Ota T.,Suzuki Y.,Nishikawa T.,Otsuki T.,Sugiyama T.,Irie R.,Wakamatsu A.,Hayashi K.,Sato H.,Nagai K.,Kimura K.,Makita H.,Sekine M.,Obayashi M.,Nishi T.,Shibahara T.,Tanaka T.,Ishii S.,Yamamoto J.,Saito K.,Kawai Y.,Isono Y.,Nakamura Y.,Nagahari K.,Murakami K.,Yasuda T.,Iwayanagi T.,Wagatsuma M.,Shiratori A.,Sudo H.,Hosoiri T.,Kaku Y.,Kodaira H.,Kondo H.,Sugawara M.,Takahashi M.,Kanda K.,Yokoi T.,Furuya T.,Kikkawa E.,Omura Y.,Abe K.,Kamihara K.,Katsuta N.,Sato K.,Tanikawa M.,Yamazaki M.,Ninomiya K.,Ishibashi T.,Yamashita H.,Murakawa K.,Fujimori K.,Tanai H.,Kimata M.,Watanabe M.,Hiraoka S.,Chiba Y.,Ishida S.,Ono Y.,Takiguchi S.,Watanabe S.,Yosida M.,Hotuta T.,Kusano J.,Kanehori K.,Takahashi-Fujii A.,Hara H.,Tanase T.-O.,Nomura Y.,Togiya S.,Komai F.,Hara R.,Takeuchi K.,Arita M.,Imose N.,Musashino K.,Yuuki H.,Oshima A.,Sasaki N.,Aotsuka S.,Yoshikawa Y.,Matsunawa H.,Ichihara T.,Shiohata N.,Sano S.,Moriya S.,Momiyama H.,Satoh N.,Takami S.,Terashima Y.,Suzuki O.,Nakagawa S.,Senoh A.,Mizoguchi H.,Goto Y.,Shimizu F.,Wakebe H.,Hishigaki H.,Watanabe T.,Sugiyama A.,Takemoto M.,Kawakami B.,Yamazaki M.,Watanabe K.,Kumagai A.,Itakura S.,Fukuzumi Y.,Fujimori Y.,Komiyama M.,Tashiro H.,Tanigami A.,Fujiwara T.,Ono T.,Yamada K.,Fujii Y.,Ozaki K.,Hirao M.,Ohmori Y.,Kawabata A.,Hikiji T.,Kobatake N.,Inagaki H.,Ikema Y.,Okamoto S.,Okitani R.,Kawakami T.,Noguchi S.,Itoh T.,Shigeta K.,Senba T.,Matsumura K.,Nakajima Y.,Mizuno T.,Morinaga M.,Sasaki M.,Togashi T.,Oyama M.,Hata H.,Watanabe M.,Komatsu T.,Mizushima-Sugano J.,Satoh T.,Shirai Y.,Takahashi Y.,Nakagawa K.,Okumura K.,Nagase T.,Nomura N.,Kikuchi H.,Masuho Y.,Yamashita R.,Nakai K.,Yada T.,Nakamura Y.,Ohara O.,Isogai T.,Sugano S.
Complete sequencing and characterization of 21,243 full-length human cDNAs.
Nat. Genet.
36
40-45
2004
783936
Mungall A.J.,Palmer S.A.,Sims S.K.,Edwards C.A.,Ashurst J.L.,Wilming L.,Jones M.C.,Horton R.,Hunt S.E.,Scott C.E.,Gilbert J.G.R.,Clamp M.E.,Bethel G.,Milne S.,Ainscough R.,Almeida J.P.,Ambrose K.D.,Andrews T.D.,Ashwell R.I.S.,Babbage A.K.,Bagguley C.L.,Bailey J.,Banerjee R.,Barker D.J.,Barlow K.F.,Bates K.,Beare D.M.,Beasley H.,Beasley O.,Bird C.P.,Blakey S.E.,Bray-Allen S.,Brook J.,Brown A.J.,Brown J.Y.,Burford D.C.,Burrill W.,Burton J.,Carder C.,Carter N.P.,Chapman J.C.,Clark S.Y.,Clark G.,Clee C.M.,Clegg S.,Cobley V.,Collier R.E.,Collins J.E.,Colman L.K.,Corby N.R.,Coville G.J.,Culley K.M.,Dhami P.,Davies J.,Dunn M.,Earthrowl M.E.,Ellington A.E.,Evans K.A.,Faulkner L.,Francis M.D.,Frankish A.,Frankland J.,French L.,Garner P.,Garnett J.,Ghori M.J.,Gilby L.M.,Gillson C.J.,Glithero R.J.,Grafham D.V.,Grant M.,Gribble S.,Griffiths C.,Griffiths M.N.D.,Hall R.,Halls K.S.,Hammond S.,Harley J.L.,Hart E.A.,Heath P.D.,Heathcott R.,Holmes S.J.,Howden P.J.,Howe K.L.,Howell G.R.,Huckle E.,Humphray S.J.,Humphries M.D.,Hunt A.R.,Johnson C.M.,Joy A.A.,Kay M.,Keenan S.J.,Kimberley A.M.,King A.,Laird G.K.,Langford C.,Lawlor S.,Leongamornlert D.A.,Leversha M.,Lloyd C.R.,Lloyd D.M.,Loveland J.E.,Lovell J.,Martin S.,Mashreghi-Mohammadi M.,Maslen G.L.,Matthews L.,McCann O.T.,McLaren S.J.,McLay K.,McMurray A.,Moore M.J.F.,Mullikin J.C.,Niblett D.,Nickerson T.,Novik K.L.,Oliver K.,Overton-Larty E.K.,Parker A.,Patel R.,Pearce A.V.,Peck A.I.,Phillimore B.J.C.T.,Phillips S.,Plumb R.W.,Porter K.M.,Ramsey Y.,Ranby S.A.,Rice C.M.,Ross M.T.,Searle S.M.,Sehra H.K.,Sheridan E.,Skuce C.D.,Smith S.,Smith M.,Spraggon L.,Squares S.L.,Steward C.A.,Sycamore N.,Tamlyn-Hall G.,Tester J.,Theaker A.J.,Thomas D.W.,Thorpe A.,Tracey A.,Tromans A.,Tubby B.,Wall M.,Wallis J.M.,West A.P.,White S.S.,Whitehead S.L.,Whittaker H.,Wild A.,Willey D.J.,Wilmer T.E.,Wood J.M.,Wray P.W.,Wyatt J.C.,Young L.,Younger R.M.,Bentley D.R.,Coulson A.,Durbin R.M.,Hubbard T.,Sulston J.E.,Dunham I.,Rogers J.,Beck S.
The DNA sequence and analysis of human chromosome 6.
Nature
425
805-811
2003
783938
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
Genome Res.
14
2121-2127
2004
783939
Collier S.,Tassabehji M.,Sinnott P.,Strachan T.
A de novo pathological point mutation at the 21-hydroxylase locus: implications for gene conversion in the human genome.
Nat. Genet.
3
260-265
1993
783940
Carroll M.C.,Campbell R.D.,Porter R.R.
Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man.
Proc. Natl. Acad. Sci. U.S.A.
82
521-525
1985
783941
Amor M.,Parker K.L.,Globerman H.,New M.I.,White P.C.
Mutation in the CYP21B gene (Ile-172-->Asn) causes steroid 21-hydroxylase deficiency.
Proc. Natl. Acad. Sci. U.S.A.
85
1600-1604
1988
783942
Matteson K.J.,Phillips J.A. III,Miller W.L.,Chung B.C.,Orlando P.J.,Frisch H.,Ferrandez A.,Burr I.M.
P450XXI (steroid 21-hydroxylase) gene deletions are not found in family studies of congenital adrenal hyperplasia.
Proc. Natl. Acad. Sci. U.S.A.
84
5858-5862
1987
783943
Tajima T.,Okada T.,Ma X.M.,Ramsey W.,Bornstein S.,Aguilera G.
Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochromeP450 21-hydroxylase into the adrenal gland of21-hydroxylase-deficient mice.
Gene Ther.
6
1898-1903
1999
783944
Pallan P.S.,Wang C.,Lei L.,Yoshimoto F.K.,Auchus R.J.,Waterman M.R.,Guengerich F.P.,Egli M.
Human Cytochrome P450 21A2, the major steroid 21-hydroxylase: structure of the enzyme-progesterone substrate complex and rate-limiting c-h bond cleavage.
J. Biol. Chem.
290
13128-13143
2015
783945
Wu D.-A.,Chung B.-C.
Mutations of P450c21 (steroid 21-hydroxylase) at Cys428, Val281, and Ser268 result in complete, partial, or no loss of enzymatic activity, respectively.
J. Clin. Invest.
88
519-523
1991
783947
White P.C.,Tusie-Luna M.-T.,New M.I.,Speiser P.W.
Mutations in steroid 21-hydroxylase (CYP21).
Hum. Mutat.
3
373-378
1994
783948
Speiser P.W.,New M.I.,White P.C.
Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1.
N. Engl. J. Med.
319
19-23
1988
783949
Chiou S.-H.,Hu M.-C.,Chung B.-C.
A missense mutation at Ile172-->Asn or Arg356-->Trp causes steroid 21-hydroxylase deficiency.
J. Biol. Chem.
265
3549-3552
1990
783950
Partanen J.,Campbell R.D.
Substitution of Ile-172 to Asn in the steroid 21-hydroxylase B (P450c21B) gene in a Finnish patient with the simple virilizing form of congenital adrenal hyperplasia.
Hum. Genet.
87
716-720
1991
783951
Tusie-Luna M.T.,Speiser P.W.,Dumic M.,New M.I.,White P.C.
A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele.
Mol. Endocrinol.
5
685-692
1991
783952
Speiser P.W.,Dupont J.,Zhu D.,Serrat J.,Buegeleisen M.,Tusie-Luna M.-T.,Lesser M.,New M.I.,White P.C.
Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
J. Clin. Invest.
90
584-595
1992
783953
Owerbach D.,Sherman L.,Ballard A.L.,Azziz R.
Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency.
Mol. Endocrinol.
6
1211-1215
1992
783954
Wedell A.,Ritzen E.M.,Haglund-Stengler B.,Luthman H.
Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations.
Proc. Natl. Acad. Sci. U.S.A.
89
7232-7236
1992
783955
Wedell A.,Luthman H.
Steroid 21-hydroxylase (P450c21): a new allele and spread of mutations through the pseudogene.
Hum. Genet.
91
236-240
1993
783956
Barbat B.,Bogyo A.,Raux-Demay M.-C.,Kuttenn F.,Boue J.,Simon-Bouy B.,Serre J.-L.,Boue A.,Mornet E.
Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency.
Hum. Mutat.
5
126-130
1995
783957
Kirby-Keyser L.,Porter C.C.,Donohoue P.A.
E380D: a novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Hum. Mutat.
9
181-182
1997
783958
Lajic S.,Levo A.,Nikoshkov A.,Lundberg Y.,Partanen J.,Wedell A.
A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction.
Hum. Genet.
99
704-709
1997
783959
Nikoshkov A.,Lajic S.,Holst M.,Wedell A.,Luthman H.
Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency.
J. Clin. Endocrinol. Metab.
82
194-199
1997
783960
Ordonez-Sanchez M.L.,Ramirez-Jimenez S.,Lopez-Gutierrez A.U.,Riba L.,Gamboa-Cardiel S.,Cerrillo-Hinojosa M.,Altamirano-Bustamante N.,Calzada-Leon R.,Robles-Valdes C.,Mendoza-Morfin F.,Tusie-Luna M.T.
Molecular genetic analysis of patients carrying steroid 21-hydroxylase deficiency in the Mexican population: identification of possible new mutations and high prevalence of apparent germ-line mutations.
Hum. Genet.
102
170-177
1998
783961
Nikoshkov A.,Lajic S.,Vlamis-Gardikas A.,Tranebjaerg L.,Holst M.,Wedell A.,Luthman H.
Naturally occurring mutants of human steroid 21-hydroxylase (P450c21) pinpoint residues important for enzyme activity and stability.
J. Biol. Chem.
273
6163-6165
1998
783962
Lajic S.,Nikoshkov A.,Holst M.,Wedell A.
Effects of missense mutations and deletions on membrane anchoring and enzyme function of human steroid 21-hydroxylase (P450c21).
Biochem. Biophys. Res. Commun.
257
384-390
1999
783963
Lobato M.N.,Ordonez-Sanchez M.L.,Tusie-Luna M.T.,Meseguer A.
Mutation analysis in patients with congenital adrenal hyperplasia in the Spanish population: identification of putative novel steroid 21-hydroxylase deficiency alleles associated with the classic form of the disease.
Hum. Hered.
49
169-175
1999
783964
Witchel S.F.,Smith R.,Suda-Hartman M.
Identification of CYP21 mutations, one novel, by single strand conformational polymorphism (SSCP) analysis.
Hum. Mutat.
13
172-172
1999
783965
Ohlsson G.,Mueller J.,Skakkebaek N.E.,Schwartz M.
Steroid 21-hydroxylase deficiency: mutational spectrum in Denmark, three novel mutations, and in vitro expression analysis.
Hum. Mutat.
13
482-486
1999
783966
Kapelari K.,Ghanaati Z.,Wollmann H.,Ventz M.,Ranke M.B.,Kofler R.,Peters H.
A rapid screening for steroid 21-hydroxylase mutations in patients with congenital adrenal hyperplasia.
Hum. Mutat.
13
505-505
1999
783967
Billerbeck A.E.C.,Bachega T.A.S.S.,Frazatto E.T.,Nishi M.Y.,Goldberg A.C.,Marin M.L.C.,Madureira G.,Monte O.,Arnhold I.J.P.,Mendonca B.B.
A novel missense mutation, GLY424SER, in Brazilian patients with 21-hydroxylase deficiency.
J. Clin. Endocrinol. Metab.
84
2870-2872
1999
783968
Asanuma A.,Ohura T.,Ogawa E.,Sato S.,Igarashi Y.,Matsubara Y.,Iinuma K.
Molecular analysis of Japanese patients with steroid 21-hydroxylase deficiency.
J. Hum. Genet.
44
312-317
1999
783969
Lako M.,Ramsden S.,Campbell R.D.,Strachan T.
Mutation screening in British 21-hydroxylase deficiency families and development of novel microsatellite based approaches to prenatal diagnosis.
J. Med. Genet.
36
119-124
1999
783970
Cargill M.,Altshuler D.,Ireland J.,Sklar P.,Ardlie K.,Patil N.,Shaw N.,Lane C.R.,Lim E.P.,Kalyanaraman N.,Nemesh J.,Ziaugra L.,Friedland L.,Rolfe A.,Warrington J.,Lipshutz R.,Daley G.Q.,Lander E.S.
Characterization of single-nucleotide polymorphisms in coding regions of human genes.
Nat. Genet.
22
231-238
1999
783972
Krone N.,Braun A.,Roscher A.A.,Knorr D.,Schwarz H.P.
Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.
J. Clin. Endocrinol. Metab.
85
1059-1065
2000
783973
Loke K.Y.,Lee Y.S.,Lee W.W.R.,Poh L.K.S.
Molecular analysis of CYP-21 mutations for congenital adrenal hyperplasia in Singapore.
Horm. Res.
55
179-184
2001
783974
Deneux C.,Tardy V.,Dib A.,Mornet E.,Billaud L.,Charron D.,Morel Y.,Kuttenn F.
Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
J. Clin. Endocrinol. Metab.
86
207-213
2001
783975
Baumgartner-Parzer S.M.,Schulze E.,Waldhaeusl W.,Pauschenwein S.,Rondot S.,Nowotny P.,Meyer K.,Frisch H.,Waldhauser F.,Vierhapper H.
Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation.
J. Clin. Endocrinol. Metab.
86
4771-4775
2001
783976
Levo A.,Partanen J.
Novel mutations in the human CYP21 gene.
Prenat. Diagn.
21
885-889
2001
783977
Ezquieta B.,Cueva E.,Varela J.,Oliver A.,Fernandez J.,Jariego C.
Non-classical 21-hydroxylase deficiency in children: association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations.
Acta Paediatr.
91
892-898
2002
783978
Lajic S.,Clauin S.,Robins T.,Vexiau P.,Blanche H.,Bellanne-Chantelot C.,Wedell A.
Novel mutations in CYP21 detected in individuals with hyperandrogenism.
J. Clin. Endocrinol. Metab.
87
2824-2829
2002
783979
Billerbeck A.E.C.,Mendonca B.B.,Pinto E.M.,Madureira G.,Arnhold I.J.P.,Bachega T.A.S.S.
Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due to a founder effect.
J. Clin. Endocrinol. Metab.
87
4314-4317
2002
783980
Dolzan V.,Stopar-Obreza M.,Zerjav-Tansek M.,Breskvar K.,Krzisnik C.,Battelino T.
Mutational spectrum of congenital adrenal hyperplasia in Slovenian patients: a novel Ala15Thr mutation and Pro30Leu within a larger gene conversion associated with a severe form of the disease.
Eur. J. Endocrinol.
149
137-144
2003
783981
Pinto G.,Tardy V.,Trivin C.,Thalassinos C.,Lortat-Jacob S.,Nihoul-Fekete C.,Morel Y.,Brauner R.
Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management.
J. Clin. Endocrinol. Metab.
88
2624-2633
2003
783982
Stikkelbroeck N.M.,Hoefsloot L.H.,de Wijs I.J.,Otten B.J.,Hermus A.R.,Sistermans E.A.
CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations.
J. Clin. Endocrinol. Metab.
88
3852-3859
2003
783983
Kharrat M.,Tardy V.,M'Rad R.,Maazoul F.,Jemaa L.B.,Refai M.,Morel Y.,Chaabouni H.
Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation.
J. Clin. Endocrinol. Metab.
89
368-374
2004
783984
Usui T.,Nishisho K.,Kaji M.,Ikuno N.,Yorifuji T.,Yasuda T.,Kuzuya H.,Shimatsu A.
Three novel mutations in Japanese patients with 21-hydroxylase deficiency.
Horm. Res.
61
126-132
2004
783985
Barbaro M.,Lajic S.,Baldazzi L.,Balsamo A.,Pirazzoli P.,Cicognani A.,Wedell A.,Cacciari E.
Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia.
J. Clin. Endocrinol. Metab.
89
2402-2407
2004
783986
Zeng X.,Witchel S.F.,Dobrowolski S.F.,Moulder P.V.,Jarvik J.W.,Telmer C.A.
Detection and assignment of CYP21 mutations using peptide mass signature genotyping.
Mol. Genet. Metab.
82
38-47
2004
783987
Grigorescu Sido A.,Weber M.M.,Grigorescu Sido P.,Clausmeyer S.,Heinrich U.,Schulze E.
21-Hydroxylase and 11beta-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia.
J. Clin. Endocrinol. Metab.
90
5769-5773
2005
783988
Grischuk Y.,Rubtsov P.,Riepe F.G.,Groetzinger J.,Beljelarskaia S.,Prassolov V.,Kalintchenko N.,Semitcheva T.,Peterkova V.,Tiulpakov A.,Sippell W.G.,Krone N.
Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia: identification, functional characterization, and structural analysis.
J. Clin. Endocrinol. Metab.
91
4976-4980
2006
783989
Menassa R.,Tardy V.,Despert F.,Bouvattier-Morel C.,Brossier J.P.,Cartigny M.,Morel Y.
p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency.
J. Clin. Endocrinol. Metab.
93
1901-1908
2008
783990
Soardi F.C.,Barbaro M.,Lau I.F.,Lemos-Marini S.H.,Baptista M.T.,Guerra-Junior G.,Wedell A.,Lajic S.,de Mello M.P.
Inhibition of CYP21A2 enzyme activity caused by novel missense mutations identified in Brazilian and Scandinavian patients.
J. Clin. Endocrinol. Metab.
93
2416-2420
2008
783991
Riepe F.G.,Hiort O.,Grotzinger J.,Sippell W.G.,Krone N.,Holterhus P.M.
Functional and structural consequences of a novel point mutation in the CYP21A2 gene causing congenital adrenal hyperplasia: potential relevance of helix C for P450 oxidoreductase-21-hydroxylase interaction.
J. Clin. Endocrinol. Metab.
93
2891-2895
2008
783992
Tardy V.,Menassa R.,Sulmont V.,Lienhardt-Roussie A.,Lecointre C.,Brauner R.,David M.,Morel Y.
Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier.
J. Clin. Endocrinol. Metab.
95
1288-1300
2010
783993
Niceta M.,Bono M.,Fabiano C.,Pojero F.,Niceta F.,Sammarco P.,Corsello G.,Garofalo P.
A large view of CYP21 locus among Sicilians and other populations: identification of a novel CYP21A2 variant in Sicily.
J. Endocrinol. Invest.
34
847-854
2011
783994
Concolino P.,Mello E.,Patrosso M.C.,Penco S.,Zuppi C.,Capoluongo E.
p.H282N and p.Y191H: 2 novel CYP21A2 mutations in Italian congenital adrenal hyperplasia patients.
Metabolism
61
519-524
2012
783995
de Paula Michelatto D.,Karlsson L.,Lusa A.L.,Silva C.D.,Oestberg L.J.,Persson B.,Guerra-Junior G.,de Lemos-Marini S.H.,Barbaro M.,de Mello M.P.,Lajic S.
Functional and structural consequences of nine CYP21A2 mutations ranging from very mild to severe effects.
Int. J. Endocrinol.
2016
4209670-4209670
2016